Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/28/11  and contains information from public web pages.

Mr. James Vincent Sheridan

Wrong James Vincent Sheridan?

Developer

Protocel
 
Background

Employment History

  • Inventor
    Protocel
  • Member, Staff
    Detroit Institute of Cancer Research
  • Scientist
    Detroit Institute of Cancer Research
  • Biochemist
    The Dow Chemical Company
  • Chemist
    The Dow Chemical Company
  • Developer and Inventor
    Entelev/Cancell
  • Original Inventor
    Entelev/Cancell
  • Inventor
    Cancell

Board Memberships and Affiliations

  • Founder
    Protocel

Education

  • High School
  • University of Pittsburgh
79 Total References
Web References
From everything I've read, Jim ...
www.TheBreastStaysPut.com, 28 Sept 2011 [cached]
From everything I've read, Jim Sheridan, the developer of Protocel®, recommended that people eat the typical American diet while on Protocel® for cancer.
Drs. Willliam Kelley and Jim ...
www.thyrodren.com [cached]
Drs. Willliam Kelley and Jim Sheridan, founder of Protocel, are among the doctors described in a separate article on this website entitled The Cancer Pioneers.
Keep in mind that Tony Bell ...
www.protocelforum.com, 23 Aug 2008 [cached]
Keep in mind that Tony Bell is a chemist and worked with Jim Sheridan, the inventor of Protocel.
...
Tony got his information about dosage from Sheridan.
Orion Therapeutics LLC | Alternative Therapies
www.oriontherapeutics.com, 29 Aug 2011 [cached]
In the late 1930's, Jim Sheridan, a chemist working at the Dow Chemical Company, developed the first product Entelev®. He later continued developing and testing the formula while working at the Detroit Institute of Cancer Research (which became the Michigan Cancer Foundation), and at Batelle in Ohio during the 1950's. From the late 1970's through the mid 1990's, the formula was produced under Mr. Sheridan's control as Cancell®.
During his career, he provided it free of charge to a multitude of terminally ill cancer patients with a great number of anecdotal positive outcomes and cures being reported.
...
It was originally designed by Jim Sheridan, as noted previously, as an anticancer agent and has been used by cancer patients since the 1970's; there is an abundance of anecdotal and testimonial data concerning its cancer efficacy.
cancerinfo2
www.detailshere.com, 1 Jan 2000 [cached]
The developer, James Sheridan wished Cancell to be affordable to all cancer sufferers in the world. In negotiations with drug companies he insisted on reasonable prices.
...
The developer, James Sheridan, felt that Cancell would have completely eliminated the tumor masses if the test was conducted for a longer period.
...
The FDA harassed the developer James Sheridan and prevented labs from testing his compound. Eventually they placed an injunction against him from distributing Cancell even though no one had reported any adverse side effects.
The FDA's position on Cancell may look different from their point of view. Sheridan was distributing a compound that FDA did not approve, therefore the FDA felt obliged to stop his operation.
...
Meanwhile, Sheridan can't even get acknowledged by the medical community because he isn't a medical doctor.
Return to Main Menu or view Site Map
Effectiveness and Response Time
By 1940, Sheridan had a compound which he tested to be 38% effective. He continued improving the formulation using laboratory animals. Eventually over 20,000 animal experiments were performed and, by 1953 the development stage ended.
...
Although Sheridan was unable to get a lab to perform a toxicity test on Entelev, one interested group succeeded in getting the test performed by changing the name.
...
Entelev was developed by a chemist, James Sheridan of Rosell, Michigan. Since his original formula the following names have been used: Sheridan's Formula, Jim's Juice, Crocinic Acid, JS-114, JS-101, 126-F, Entelev, Cancell, Cantron, and Protocel.
Sheridan theorized the possibility of chemically controlling the energy needed by the cells of our body to cause energy low cancer cells to revert to a state where the body can eliminate them as foreign matter. The theory postulates that cancer cells are too energy low to proceed with their normal development. Cancer cells stop their development just short of differentiating into a normal liver, lung, brain ... cell. Sheridan proposed to push cancer cells backward in their development instead of try to encourage them to differentiate.
Sheridan believed he had found a method of controlling the energy available to cells in the early 1930s after witnessing a chemical reaction called rhythmic banding in an analytical chemistry laboratory at Carnegie Tech and reading the Debye Theory, published in 1927 which explores the effects of changing the dielectric constant on reactions of positive and negative ions suggested the means to accomplish this energy reduction.
About 1950, Sheridan was invited to join the staff of the Detroit Institute of Cancer Research. There he performed the required chemical work on the project and the institute experts performed the animal tests.
...
They returned and reported that the American Cancer Society did not approve the test because Mr. Sheridan did not prove that he owned the idea. Sheridan was later fired.
Since Sherdian had worked on his idea for many years, it would be fairly easy to show that the idea was his, but Sheridan was fired.
...
Based on the animal testing, Sheridan knew that Entelev was non-toxic and started giving it to friends who were at the "end of the line. Word spread of the effects it had on these people and Sheridan started receiving requests from all over the country.
...
Unfortunately, Sheridan had recently quit distributing Entelev in response to a court injunction because he had not gained FDA approval. This nameless man had written six technical books, and was competent to understand the formulation so Sheridan gave it to him, but he didn't have the equipment for production.
...
Sopcak agreed to make it and eventually started working with Sheridan and distributing it for free between 1984 and 1992.
...
Sheridan and Sopcak decided to pay for this testing because they couldn't get help from the drug company influenced cancer agencies.
...
Sheridan found what he considered the best laboratory in the country in New Mexico. The cost of the toxicity test was originally $5,000. After they got the material, they called Jim and said it would cost $7,000. Sheridan and Sopcak still agreed.
...
Still Sheridan and Sopcak agreed.
...
Eventually, Sheridan retired and no longer pursues the battle.
Return to Main Menu or view Site Map
The Formulation Change / Name Confusion / Reputation Destruction
Ed Sopcak worked with James Sheridan, the developer, by distributing Entelev (the original name for Cancell, see History above) under the name Cancell between 1984 and 1992.
...
Sopcak's new formula was completely clear and contained none of the chemicals that Sheridan had specified.
Other People with the name "Sheridan":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304